In our analysis of MTAP deficient NSCLC subjects, while the overall KRAS or STK11 genomic alterations did not show any significant difference, KRAS G12C mutations were lower in MTAP‐loss versus MTAP‐intact tumors. Here, MTAP is linked to non-small cell lung carcinoma.